- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Aurobindo Pharma's Unit-VII US FDA inspection concluded with 9 procedural observations on Form 483. The company will address these. Management states no impact on financials or operations.